Physician profile
Arthur D Clode
NPI 1992747257
$5,061.23
in general payments reported to CMS, 2019-2025
26 companies · $1,006 in 2025
The $1,006 reported for 2025 was more than what 86% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $477 · 2020: $243 · 2021: $578 · 2022: $703 · 2023: $848 · 2024: $1,207 · 2025: $1,006.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,061.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $547.76 | 2023-2025 | |
| Stryker Corporation | $449.31 | 2021-2025 | Prostep Mica |
| Abbott Laboratories | $448.45 | 2019-2024 | Proclaim |
| Horizon Therapeutics Plc | $445.91 | 2019-2021 | |
| Linvatec Corporation | $267.62 | 2023-2025 | Colink 2, Quantum, In2bones USA |
| Smith+Nephew, INC. | $267.46 | 2020-2024 | Pico, Renasys Go V2 Home, Renasys Touch |
| Nevro Corp. | $262.61 | 2023-2024 | Senza |
| Organogenesis INC. | $251.91 | 2022-2023 | Puraply |
| Aroa Biosurgery Incorporated | $185.79 | 2024-2025 | |
| Next Science LLC | $185.15 | 2022-2024 | Xperience, Surgx, Blastx |
| Sanara Medtech INC. | $170.87 | 2023 | Celleraterx |
| In2bones USA, LLC | $150.09 | 2022 | |
| Forma Medical | $146.66 | 2025 | Optimalmtp |
| Depuy Synthes Sales INC. | $140.76 | 2021-2024 | Hammerlock |
| Acera Surgical, INC. | $139.79 | 2024 | Restrata Wound Matrix |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $130.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $129.41 | 2024 | Krystexxa |
| Djo, LLC | $127.37 | 2024-2025 | Cmf |
| Solventum Corporation | $124.14 | 2025 | Activ.A.C., Promogran Prisma |
| Orthofix Medical, INC. | $111.94 | 2023 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $110.34 | 2024 | Nuzyra |
| Cardiovascular Systems INC. | $86.85 | 2020 | |
| Kci USA, INC. | $80.31 | 2021 | |
| Mimedx Group, INC. | $57.98 | 2025 | |
| Mvp Orthopedics INC | $23.06 | 2022 | |
| Bsn Medical INC | $19.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Clode listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.